Canada - English - Health Canada

ipsen biopharmaceuticals canada inc - cabozantinib (cabozantinib malate) - tablet - 40mg - cabozantinib (cabozantinib malate) 40mg - antineoplastic agents

Canada - English - Health Canada

ipsen biopharmaceuticals canada inc - cabozantinib (cabozantinib malate) - tablet - 60mg - cabozantinib (cabozantinib malate) 60mg - antineoplastic agents

Canada - English - Health Canada

eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 4mg - lenvatinib (lenvatinib mesylate) 4mg - antineoplastic agents

Canada - English - Health Canada

eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 12mg - lenvatinib (lenvatinib mesylate) 12mg - antineoplastic agents

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sharda cropchem espana s.l - thiabendazole - suspension concentrate - thiabendazole thiazole active 500.0 g/l - fungicide

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria. primaquine phosphate is contraindicated in acutely ill patients suffering from systemic disease manifested by tendency to granulocytopenia, such as rheumatoid arthritis and lupus erythematosus. the drug is also contraindicated in patients receiving concurrently other potentially hemolytic drugs or depressants of myeloid elements of the bone marrow. because quinacrine hydrochloride appears to potentiate the toxicity of antimalarial compounds which are structurally related to primaquine, the use of quinacrine in patients receiving primaquine is contraindicated. similarly, primaquine should not be administered to patients who have received quinacrine recently, as toxicity is increased.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria. primaquine phosphate is contraindicated in acutely ill patients suffering from systemic disease manifested by tendency to granulocytopenia, such as rheumatoid arthritis and lupus erythematosus. the drug is also contraindicated in patients receiving concurrently other potentially hemolytic drugs or depressants of myeloid elements of the bone marrow. because quinacrine hydrochloride appears to potentiate the toxicity of antimalarial compounds which are structurally related to primaquine, the use of quinacrine in patients receiving primaquine is contraindicated. similarly, primaquine should not be administered to patients who have received quinacrine recently, as toxicity is increased.

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria. severe glucose-6-phosphate dehydrogenase (g6pd) deficiency (see warnings). pregnant women (see warnings, usage in pregnancy). primaquine phosphate is contraindicated in acutely ill patients suffering from systemic disease manifested by tendency to granulocytopenia, such as rheumatoid arthritis and lupus erythematosus. the drug is also contraindicated in patients receiving concurrently other potentially hemolytic drugs or depressants of myeloid elements of the bone marrow. because quinacrine hydrochloride appears to potentiate the toxicity of antimalarial compounds which are structurally related to primaquine, the use of quinacrine in patients receiving primaquine is contraindicated. similarly, primaquine should not be administered to patients who have received quinacrine recently, as toxicity is increased.

United States - English - NLM (National Library of Medicine)

phibro animal health - poloxalene (unii: v8b3k56sw0) (poloxalene - unii:v8b3k56sw0) - for use in the manufacture of feed for prevention of legume (alfalfa, clover) and wheat pasture bloat in cattle

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - dacominitib monohydrate -